ArticleDermatology and therapy2023

Publisher Correction: Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2).

Paolo Gisondi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.